Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 61 entries
View as:

Thromboembolic Risk Screening in Patients With Cancer and COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04616846 Org: User:
Start: 08/04/20 End: 01/25/22 Due: 01/25/23

Per-Operative Radiotherapy by Papillon +TM in Localized Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04680715 Org: User:
Start: 07/16/21 End: 06/30/28 Due: 06/30/29

Single Fraction Elderly Breast Irradiation (SiFEBI)

Phase: N/A Priority: Normal
NCT ID: NCT01727011 Org: User:
Start: 11/30/12 End: 11/30/15 Due: 11/30/16

Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study

Phase: N/A Priority: Normal
NCT ID: NCT03325738 Org: User:
Start: 06/30/17 End: 09/11/18 Due: 09/11/19

Evaluation of Patient Satisfaction With and Acceptance of Their Totally-implanted Central Venous Catheter

Phase: N/A Priority: Normal
NCT ID: NCT01616537 Org: User:
Start: 11/30/11 End: 12/31/13 Due: 12/31/14

Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme

Phase: N/A Priority: Normal
NCT ID: NCT02331498 Org: User:
Start: 06/30/15 End: 08/31/30 Due: 08/31/31

Gemcitabine, Capecitabine, and Erlotinib in Treating Patients With Advanced Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00885066 Org: User:
Start: 05/31/08 End: 10/31/09 Due: 10/31/10

Modification of the Quality of Life Based on Objective Geriatric Tests

Phase: N/A Priority: Normal
NCT ID: NCT02873533 Org: User:
Start: 03/31/13 End: 04/01/19 Due: 04/01/20

Impact of a Telephonic Monitoring During Inter-treatment Intervals on Emotional State, Quality of Life and Toxicities, on Neo Adjuvant or Adjuvant Chemotherapy-treated Patients

Phase: N/A Priority: Normal
NCT ID: NCT01977053 Org: User:
Start: 09/30/13 End: 12/31/18 Due: 12/31/19

Individual Following in Anal Cancer With PET/CT

Phase: N/A Priority: Normal
NCT ID: NCT02697084 Org: User:
Start: 11/30/14 End: 10/31/21 Due: 10/31/22

Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06833229 Org: User:
Start: 01/27/22 End: 01/27/31 Due: 01/27/32

Information Consultation by Radiotherapy Manipulator

Phase: N/A Priority: Normal
NCT ID: NCT02867462 Org: User:
Start: 04/30/13 End: 05/10/17 Due: 05/10/18

Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy

Phase: N/A Priority: Normal
NCT ID: NCT06400849 Org: User:
Start: 04/04/24 End: 06/04/27 Due: 06/04/28

High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03126487 Org: User:
Start: 04/25/17 End: 01/11/18 Due: 01/11/19

Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive Tract

Phase: N/A Priority: Normal
NCT ID: NCT00765440 Org: User:
Start: 07/31/07 End: 04/30/11 Due: 04/30/12

THrombo-Embolic Event in Onco-hematology

Phase: N/A Priority: Normal
NCT ID: NCT03826043 Org: User:
Start: 09/09/19 End: 09/09/22 Due: 09/09/23

Preoperative Localization of Infraclinical Breast Tumors: Isotopic Localization by iodine125 Seed Versus Standard Localization Using a Metal Wire

Phase: N/A Priority: Normal
NCT ID: NCT02759133 Org: User:
Start: 06/30/16 End: 08/03/23 Due: 08/03/24

Locally Advanced NSCLC Treated With Radiochemotherapy: Phase 2 Study on the Value of a Stereotactic Boost

Phase: N/A Priority: Normal
NCT ID: NCT06627738 Org: User:
Start: 06/10/25 End: 06/30/33 Due: 06/30/34

Organoids From Metastases of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03952793 Org: User:
Start: 12/04/19 End: 10/25/21 Due: 10/25/22

Stereotactic Radiosurgery in Treating Patients Undergoing Chemotherapy and Radiation Therapy For Stage III Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00945451 Org: User:
Start: 04/24/09 End: 11/17/16 Due: 11/17/17

Development of Preclinical Models Derived From Tumors With a Molecular Abnormality of Interest to Test Their Sensitivity to New Anti-tumor Therapies.

Phase: N/A Priority: Normal
NCT ID: NCT06782451 Org: User:
Start: 05/02/25 End: 07/02/30 Due: 07/02/31

Virtual Reality for Children in Radiotherapy (REVER)

Phase: N/A Priority: Normal
NCT ID: NCT04934293 Org: User:
Start: 08/02/21 End: 02/28/27 Due: 02/28/28

18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03121456 Org: User:
Start: 10/13/17 End: 04/12/24 Due: 04/12/25

Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)

Phase: N/A Priority: Normal
NCT ID: NCT03114280 Org: User:
Start: 03/12/19 End: 03/12/19 Due: 03/12/20

Single Fraction Early Prostate Irradiation (SiFEPI)

Phase: N/A Priority: Normal
NCT ID: NCT02104362 Org: User:
Start: 02/28/14 End: 06/14/21 Due: 06/14/22